Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma

Published:2017-01-17 Issue:1 Volume:5 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Beckermann Kathryn E.,Jolly Pradeep C.,Kim Ju Y.,Bordeaux Jennifer,Puzanov Igor,Rathmell W. Kimryn,Johnson Douglas B.

Funder

National Cancer Institute

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-016-0206-1.pdf

Reference25 articles.

1. Davis Jr CJ, Mostofi FK, Sesterhenn IA. Renal medullary carcinoma. The seventh sickle cell nephropathy. Am J Surg Pathol. 1995;19:1–11.

2. Alvarez O, Rodriguez MM, Jordan L, Sarnaik S. Renal medullary carcinoma and sickle cell trait: a systematic review. Pediatr Blood Cancer. 2015;62:1694–9.

3. Figenshau RS, Basler JW, Ritter JH, Siegel CL, Simon JA, et al. Renal medullary carcinoma. J Urol. 1998;159:711–3.

4. Shah AY, Karam JA, Malouf GG, Rao P, Lim ZD, et al. Management and Outcomes of Patients with Renal Medullary Carcinoma: A Multi-Center Collaborative Study. BJU Int. 2016.

5. Cheng JX, Tretiakova M, Gong C, Mandal S, Krausz T, et al. Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior. Mod Pathol. 2008;21:647–52.

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiation Therapy for the Management of Renal Medullary Carcinoma: A Multi-Case Study;Clinical Genitourinary Cancer;2024-06

2. Challenges and opportunities for cancer stem cell‐targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell‐dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes;Journal of Biochemical and Molecular Toxicology;2024-05-19

3. Off‐label prescribing of immune checkpoint inhibitor therapy at a single pediatric cancer center;Cancer Medicine;2024-04

4. Colorectal medullary carcinoma: a pathological subtype with intense immune response and potential to benefit from immune checkpoint inhibitors;Expert Review of Clinical Immunology;2024-03-13

5. Response to PD-1 inhibitor in SMARCB1‑deficient undifferentiated rectal carcinoma with low TMB, proficient MMR and BRAF V600E mutation: a case report and literature review;Diagnostic Pathology;2024-01-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3